|
| Fascioquinol E |
|
Streptococcus |
Immune modulation |
Preclinical (in vivo) |
Standish AJ, et al. 2012. PLoS One |
|
| 2',4'-Dihydroxychalcone |
|
Vibrio |
HlyU |
Preclinical (in vivo) |
Imdad S, et al. 2018. Molecules |
|
| 5-Fluorouracil |
|
Staphylococcus
Vibrio |
Biofilm
Biofilm |
Preclinical (in vivo)
Preclinical (in vivo) |
Sedlmayer F, et al. 2021. Nucleic Acids Res
|
|
| N-(4-oxo-4H-thieno[3,4-c]chromen-3-yl)-3-phenylprop-2-ynamide |
|
Vibrio |
HlyU |
Preclinical (in vivo) |
Lee ZW, et al. 2019. Sci Rep |
|
| Fursultiamin |
|
Vibrio |
HlyU |
Preclinical (in vivo) |
Imdad S, et al. 2018. Front Cell Infect Microbiol |
|
Compound 8
(internal name in literature) |
|
Vibrio |
TCP (Toxin-coregulated pilus) |
Preclinical (in vivo) |
Woodbrey AK, et al. 2018. Biochemistry |
|
| (S)-(-)-Indoline-2-carboxylic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vivo) |
Liang F, et al. 2003. J Biol Chem |
|
| Lithocholic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vivo) |
Liang F, et al. 2003. J Biol Chem |
|
| 3-Nitrocinnamic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vivo) |
Liang F, et al. 2003. J Biol Chem |
|
| Triphenylacetic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vivo) |
Liang F, et al. 2003. J Biol Chem |
|
| | | |
